Le Lézard
Classified in: Health
Subject: ARTS/ENTERTAINMENT

ATW Tech Concludes an Agreement Regarding the Offering of Its Non-Dominant Canadian Operator Solutions and Its Option.vote Solution With Star Académie Broadcasted on TVA


MONTREAL, Feb. 11, 2021 (GLOBE NEWSWIRE) -- ATW Tech Inc. (the "Company" or "ATW Tech") (TSX-V: ATW), is proud to officially announce that its VoxTel division will allow Star Académie viewers to vote to save their favorite candidate during Sunday night variety shows produced by Productions Déferlantes, in collaboration with Québecor Contenu. It's an event not to be missed: the grand premiere of Star Académie this Sunday, February 14 at 7 p.m. on TVA.

"We are pleased to support the producers of popular Quebec programs for several years now, and through this, to contribute to the production of interactive programs for the greatest pleasure of viewers," stated Michel Guay, founder, president and CEO of ATW Tech.

VoxTel has been offering its voting solutions to various television programs for nearly 10 years, contributing to their attractiveness and audience loyalty. VoxTel's status as a non-dominant operator allows the company to offer, in partnership with the main Canadian operators, a reliable and recognized billing solution that is accessible to the greatest number of people. The success of this model reinforces our vision of offering a synergy of our services enabling increasingly inclusive interactions for all stakeholders.

Additional information regarding ATW Tech is available on SEDAR www.sedar.com

The TSX Venture Exchange and its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept no responsibility for the adequacy or accuracy of this release.

ATW TECH'S PROFILE

ATW Tech (TSX-V: ATW) is a financial technology company ("fintech"), owner of several recognized technology platforms such as VoxTel, Option.vote, Bloomed and Semeon. VoxTel specializes in telephone billing and alternative payment solutions for fixed and mobile lines. Option.vote offers a customized multi-method voting system for unions, political parties, professional associations and anyone looking for a secure way to reduce their voting costs and improve their participation rate. Bloomed is a cloud computing platform for managing smart data on consumers and their behaviors for both business and consumer-oriented campaigns. Semeon is a highly accurate and flexible text analysis platform for customer reviews, Semeon uses a unique combination of machine learning and Natural Language Processing (NLP) to discover significant trends in customer reviews across all channels.

SOURCE:        
                                
ATW Tech Inc.
Michel Guay
Founder, president and CEO
Tel.: 844.298.5932 ext. 301
[email protected]
www.atwtech.com



These press releases may also interest you

at 04:05
PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, today announced the introduction of GlueSEEKERtm. The new phenotypic screening platform expands the Company's capabilities in this emerging...

at 04:03
The National Comprehensive Cancer Network® (NCCN®)?a global nonprofit responsible for leading cancer treatment guidelines?is taking part in two events in Warsaw focused on advancing...

at 03:52
The 10th European Stroke Organization Congress (ESOC), held in Basel, Switzerland from May 15 to 17, 2024, showcased six studies on Sanbexin® (Edaravone and Dexborneol Concentrated Solution for Injection) and a new dosage form of sublingual tablets...

at 03:12
GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has cleared the investigational new drug (IND) application for their jointly developed MPSIIIA (Sanfilippo Syndrome Type A) treatment, GC1130A....

at 03:05
PathAI, a global leader in AI-powered pathology, today announced a new Early Access Program (EAP) to drive adoption of its AISightTM Image Management System (IMS) in Mainland Europe.1 Earlier in 2023, PathAI announced a similar program for...

at 03:00
Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of hard-to-treat cancers, today announces the completion of a $120m Series B financing to fund the development of its...



News published on and distributed by: